KR102546410B1 - Cosmetic composition for improving atopic dermatitis, skin moisturizing and skin soothing containing fermented extracts of Gynostemma pentaphyllum, Trifolium pratense and Hedera Helix - Google Patents
Cosmetic composition for improving atopic dermatitis, skin moisturizing and skin soothing containing fermented extracts of Gynostemma pentaphyllum, Trifolium pratense and Hedera Helix Download PDFInfo
- Publication number
- KR102546410B1 KR102546410B1 KR1020230003704A KR20230003704A KR102546410B1 KR 102546410 B1 KR102546410 B1 KR 102546410B1 KR 1020230003704 A KR1020230003704 A KR 1020230003704A KR 20230003704 A KR20230003704 A KR 20230003704A KR 102546410 B1 KR102546410 B1 KR 102546410B1
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- cosmetic composition
- lactobacillus
- pine
- chinensis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 239000000284 extract Substances 0.000 title claims abstract description 37
- 239000002537 cosmetic Substances 0.000 title claims abstract description 32
- 235000015724 Trifolium pratense Nutrition 0.000 title claims abstract description 26
- 235000013526 red clover Nutrition 0.000 title claims abstract description 26
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 10
- 240000002913 Trifolium pratense Species 0.000 title claims description 9
- 240000006509 Gynostemma pentaphyllum Species 0.000 title description 2
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 title description 2
- 240000008669 Hedera helix Species 0.000 title description 2
- 206010012438 Dermatitis atopic Diseases 0.000 title 1
- 201000008937 atopic dermatitis Diseases 0.000 title 1
- 230000008591 skin barrier function Effects 0.000 claims abstract description 14
- 206010003645 Atopy Diseases 0.000 claims abstract description 10
- 238000005728 strengthening Methods 0.000 claims abstract description 10
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 201000004624 Dermatitis Diseases 0.000 claims abstract description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 16
- 241000894006 Bacteria Species 0.000 claims description 8
- 239000004310 lactic acid Substances 0.000 claims description 8
- 235000014655 lactic acid Nutrition 0.000 claims description 8
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 7
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 7
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 7
- 241000192001 Pediococcus Species 0.000 claims description 6
- 241000218492 Lactobacillus crispatus Species 0.000 claims description 5
- 241000186660 Lactobacillus Species 0.000 claims description 4
- 229940039696 lactobacillus Drugs 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 3
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 3
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 3
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 3
- 241000186612 Lactobacillus sakei Species 0.000 claims description 3
- 241000192130 Leuconostoc mesenteroides Species 0.000 claims description 3
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 3
- 235000020299 breve Nutrition 0.000 claims description 3
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 3
- 244000057717 Streptococcus lactis Species 0.000 claims description 2
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 230000003064 anti-oxidating effect Effects 0.000 claims 1
- 241000018646 Pinus brutia Species 0.000 abstract description 27
- 230000000694 effects Effects 0.000 abstract description 25
- 235000008331 Pinus X rigitaeda Nutrition 0.000 abstract description 15
- 235000011613 Pinus brutia Nutrition 0.000 abstract description 15
- 230000006872 improvement Effects 0.000 abstract description 6
- 230000001747 exhibiting effect Effects 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 29
- 210000003491 skin Anatomy 0.000 description 28
- 239000004575 stone Substances 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 15
- 238000012360 testing method Methods 0.000 description 13
- 240000007332 Podocarpus macrophyllus Species 0.000 description 11
- 108020004999 messenger RNA Proteins 0.000 description 11
- 239000002609 medium Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000002131 composite material Substances 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- 230000000638 stimulation Effects 0.000 description 8
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 7
- 210000004209 hair Anatomy 0.000 description 7
- 229920002674 hyaluronan Polymers 0.000 description 7
- 229960003160 hyaluronic acid Drugs 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 6
- 102100038326 Beta-defensin 4A Human genes 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000007760 free radical scavenging Effects 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 3
- 101710125298 Beta-defensin 2 Proteins 0.000 description 3
- 101710176951 Beta-defensin 4A Proteins 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 3
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000003757 reverse transcription PCR Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 101000884714 Homo sapiens Beta-defensin 4A Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 102000003945 NF-kappa B Human genes 0.000 description 2
- 108010057466 NF-kappa B Proteins 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000016396 cytokine production Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000037351 starvation Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241000122501 Hypericum x moserianum Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000007930 Oxalis acetosella Species 0.000 description 1
- 235000008098 Oxalis acetosella Nutrition 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000736285 Sphagnum Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 108050002883 beta-defensin Proteins 0.000 description 1
- 102000012265 beta-defensin Human genes 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000008049 biological aging Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- -1 body cleanser Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- KASDHRXLYQOAKZ-ZPSXYTITSA-N pimecrolimus Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C/C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](Cl)[C@H](OC)C1 KASDHRXLYQOAKZ-ZPSXYTITSA-N 0.000 description 1
- 229960005330 pimecrolimus Drugs 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000037070 skin defense Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 돌외, 붉은토끼풀 및 서양송악잎의 복합발효추출물을 유효성분으로 함유하는 화장료 조성물에 관한 것으로서, 구체적으로는 돌외, 붉은토끼풀 및 서양송악잎의 발효추출물을 유효성분으로 함유하여 우수한 항산화, 피부 염증완화 및 피부진정, 아토피 개선, 피부 보습 및 피부 장벽강화활성을 나타내는 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition containing complex fermented extracts of Dole, Red clover, and Pine chinensis leaves as active ingredients. It relates to a cosmetic composition exhibiting skin inflammation relief and skin soothing, atopy improvement, skin moisturizing and skin barrier strengthening activity.
Description
본 발명은 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물을 유효성분으로 함유하는 화장료 조성물에 관한 것으로서, 구체적으로는 돌외, 붉은토끼풀 및 서양송악잎의 발효추출물을 유효성분으로 함유하여 우수한 항산화, 피부 염증완화 및 피부진정, 아토피 개선, 피부 보습 및 피부 장벽강화활성을 나타내는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing complex fermented extracts of sphagnum, chinensis chinensis, and pine chinensis as active ingredients. It relates to a cosmetic composition exhibiting inflammation relief and skin soothing, atopic improvement, skin moisturizing and skin barrier strengthening activity.
피부는 신체의 외부를 덮고 있는 하나의 막으로 여러 가지 외부의 자극, 장해, 건조 등의 환경요소로부터 신체를 보호해 주는 다양한 생리적 기능을 수행하여 내부 장기와 그 밖의 체내 기관을 보호 조절하는 역할을 한다. 그러나, 생체 노화로 인해 내적으로는 신진 대사를 조절하는 각종 호르몬의 분비가 감소하고, 면역 세포의 기능과 세포들의 활성이 저하된다.Skin is a membrane that covers the outside of the body and plays a role in protecting and regulating internal organs and other internal organs by performing various physiological functions that protect the body from various external stimuli, obstacles, and environmental factors such as dryness. do. However, due to biological aging, the secretion of various hormones internally controlling metabolism is reduced, and the function of immune cells and the activity of cells are lowered.
인체의 피부는 표피, 진피 및 피하지방으로 이루어진 몸의 외피로서, 다양한 환경적인 요인에 대해 신체를 보호하는 물리적 장벽의 기능, 촉각 및 온도 조절 등의 역할을 하는 것으로 알려져 있다. 피부의 방어 시스템은 외부로부터 자극이 가해지면 1차로 피지막, 2차적으로 각질층, 그리고 심한 경우에는 진피의 콜라겐 섬유가 방어하는 방식으로 작용한다Human skin is an outer layer of the body composed of epidermis, dermis, and subcutaneous fat, and is known to function as a physical barrier that protects the body from various environmental factors, and functions as a tactile sensation and temperature control. When an external stimulus is applied to the skin's defense system, the first sebaceous layer, secondarily the stratum corneum, and in severe cases, the collagen fibers of the dermis act as defenses.
피부의 각질층은 피부와 외부환경 사이의 첫 번째 장벽으로서 피부 상태를 결정짓는 중요한 요소이다. 건강한 피부의 각질층은 15~20%의 수분을 함유하고 있고, 수분이 10% 이하로 떨어지면 건조해지고 윤기와 탄력이 감소하여 주름이 증가한다. 자극물의 침투와 같은 외인성 요인이나 노화, 호르몬, 스트레스 등의 내인성 요인에 의해 결함이 발생하면 저항력이 떨어지게 되어 표피 이중 지질막의 기능저하를 가져오고 자극물에 대한 예민도를 증가시켜 민감 피부 및 건조 피부가 된다.The stratum corneum of the skin is an important factor determining the skin condition as the first barrier between the skin and the external environment. The stratum corneum of healthy skin contains 15 to 20% of water, and when the water content falls below 10%, it becomes dry, loses luster and elasticity, and wrinkles increase. When defects occur due to extrinsic factors such as penetration of irritants or endogenous factors such as aging, hormones, and stress, resistance decreases, resulting in deterioration of the function of the epidermal double lipid film and increased sensitivity to irritants, resulting in sensitive skin and dry skin. .
또한, 자극에 의해 피부 장벽 기능이 약화됨에 따라 자극 유발 물질이 각질층 내로 침입하여 자극을 유발시켜 피부 염증을 유발하며, 피부 내 수분 유지력이 약화됨에 따라 피부가 쉽게 건조해진다.In addition, as the skin barrier function is weakened by stimulation, irritation-inducing substances penetrate into the stratum corneum and cause irritation to cause skin inflammation, and as the ability to retain moisture in the skin is weakened, the skin becomes easily dry.
외적으로는 오존층 파괴로 인하여 태양 광선에 자외선 함량이 증가하게 되고, 환경 오염이 더욱 심화됨에 따라 자유 라디칼 및 활성 유해 산소 등이 증가함으로써 야기되는 과도한 물리적, 화학적 자극 및 스트레스는 피부의 정상기능 저하, 멜라닌 침착에 의한 기미, 주근깨 등의 생성 및 피부 노화현상을 촉진하여 피부를 손상시킬 수 있다.Externally, due to the destruction of the ozone layer, the amount of ultraviolet rays in the sun's rays increases, and as environmental pollution becomes more severe, excessive physical and chemical stimulation and stress caused by the increase of free radicals and active free radicals lead to a decrease in the normal function of the skin, It can damage the skin by accelerating the generation of spots and freckles due to melanin deposition and skin aging.
최근에는 천연물을 소재로 한 화장품이 인체안전성, 피부자극완화 등의 이유로 소비자에게 각광을 받고 있으며, 이에 따라 화장품 원료로서 천연물에 대한 다양한 연구가 이루어지고 있는 실정이다.In recent years, cosmetics made of natural materials have been in the limelight by consumers for reasons such as human safety and skin irritation relief, and accordingly, various studies on natural products as cosmetic raw materials are being conducted.
이러한 배경 하에서, 본 발명자들은 아토피 피부 개선효과와 피부 진정 및 보습효과를 가지는 화장료 개발을 위하여 연구하였으며, 종래 화장료로 사용되던 돌외, 붉은토끼풀, 서양송악잎을 특정 비율로 혼합하여 발효추출한 복합발효추출물이 그 상승효과에 의하여 우수한 아토피 피부개선, 항염증, 항산화 및 진정 효과를 나타낼 뿐만 아니라, 우수한 피부 보습, 피부장벽강화 효과를 나타낸다는 것을 확인하여 본 발명을 완성하였다.Under this background, the present inventors have studied to develop a cosmetic with atopic skin improvement effect and skin soothing and moisturizing effect, and a complex fermented extract obtained by fermenting and extracting a mixture of stone, red clover, and pine pine leaves, which have been used as conventional cosmetics, in a specific ratio. The present invention was completed by confirming that this synergistic effect not only exhibits excellent atopic skin improvement, anti-inflammatory, antioxidant and soothing effects, but also exhibits excellent skin moisturizing and skin barrier strengthening effects.
본 발명은 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물을 유효성분으로 함유하여 우수한 피부 개선효과를 나타내는 화장료 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a cosmetic composition that contains as active ingredients a complex fermented extract of stone, red clover, and pine pine leaf, and exhibits excellent skin-improving effects.
상기 목적을 달성하기 위하여 본 발명에 따르면 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물을 유효성분으로 함유하는 화장료 조성물이 제공된다.In order to achieve the above object, according to the present invention, there is provided a cosmetic composition containing as active ingredients a complex fermented extract of stone, trifolium pratense, and western pine leaf.
바람직하게는 상기 복합발효추출물은 돌외, 붉은토끼풀 및 서양송악잎 혼합물을 유산균으로 발효하고 추출하여 제조되는 것임을 특징으로 한다.Preferably, the composite fermented extract is characterized in that it is prepared by fermenting and extracting a mixture of stone, red clover, and pine pine leaf mixture with lactic acid bacteria.
발효에 사용되는 상기 유산균은 락토바실러스 플란타룸(Lactobacillus plantarum), 락토코커스 락티스(Lactococccus lactis), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 람노서스(Lactobacillus rhamnosus), 페디오코커스 세레비시애(Pediococcus cereviciae), 락토바실러스 브레브(Lactobacillus breve), 류코노스톡 메센테로이드(Leuconostoc mesenteroides), 비피도박테리움 비피둠(Bifidobacterium bifidum), 락토바실러스 사케이(Lactobacillus sakei) 및 락토바실러스 크리스파투스(Lactobacillus crispatus)로 이루어지는 군으로부터 선택되는 적어도 하나이다.The lactic acid bacteria used for fermentation are Lactobacillus plantarum, Lactococcus lactis, Lactobacillus bulgaricus, Lactobacillus rhamnosus, Pediococcus cerevisiae (Pediococcus cereviciae), Lactobacillus breve, Leuconostoc mesenteroides, Bifidobacterium bifidum, Lactobacillus sakei and Lactobacillus crispatus ( Lactobacillus crispatus) is at least one selected from the group consisting of.
바람직하게는 상기 복합발효추출물은 돌외, 붉은토끼풀 및 서양송악잎이 각각 1~2 : 1~2 : 1~2의 중량비로 혼합되어 추출되는 것이다.Preferably, the composite fermented extract is extracted by mixing and extracting stone, trifolium pratense, and western pine leaves in a weight ratio of 1 to 2: 1 to 2: 1 to 2, respectively.
유효성분으로서의 상기 복합발효추출물은 화장료 조성물 전체 중량에 대해 0.01 ~ 15 중량% 함유된다. The complex fermented extract as an active ingredient is contained in an amount of 0.01 to 15% by weight based on the total weight of the cosmetic composition.
상기 화장료 조성물은 항산화용, 피부 염증완화용, 피부 진정용, 아토피 피부 개선용, 피부 보습용 또는 피부 장벽강화용임을 특징으로 한다.The cosmetic composition is characterized in that it is for antioxidant, skin inflammation relief, skin soothing, atopic skin improvement, skin moisturizing or skin barrier strengthening.
본 발명의 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물은 그 상승효과에 의하여 우수한 항산화, 염증 및 자극완화, 보습 및 피부장벽강화 효과를 나타내므로, 항산화용, 피부 염증완화용, 피부 진정용, 아토피 피부 개선용, 피부 보습용 및 피부장벽 강화용 화장료로 유용하게 사용될 수 있다.The complex fermented extracts of doloeia, red clover, and pine pine leaf of the present invention exhibit excellent antioxidant, inflammation and irritation relief, moisturizing and skin barrier strengthening effects due to their synergistic effects, so they are for antioxidant, skin inflammation relief, skin soothing, It can be usefully used as a cosmetic for improving atopic skin, moisturizing the skin, and strengthening the skin barrier.
도 1은 본 발명 실시예에 따른 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물의 β-디펜신-2 발현 증가 효과를 나타내는 그래프이다. Figure 1 is a graph showing the effect of increasing the expression of β-defensin-2 of the combined fermented extracts of P. chinensis, P. chinensis, and Pine chinensis leaf according to an embodiment of the present invention.
이하 본 발명을 더욱 구체적으로 설명한다. Hereinafter, the present invention will be described in more detail.
본 발명에 따르면, 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물을 유효성분으로 함유하는 화장료 조성물이 제공된다.According to the present invention, there is provided a cosmetic composition containing as active ingredients a composite fermented extract of dolwei, red clover, and western pine leaves.
돌외(Gynostemma pentaphyllum)는 쌍떡잎식물 박목 박과의 여러해살이 덩굴식물이다. 산이나 들의 숲 속에서 자란다. 뿌리줄기는 옆으로 뻗고 마디에 흰털이 있고 엉키면서 자라지만 덩굴손으로 기어 올라가기도 한다. 잎은 어긋나고 5개의 작은 잎을 가진 겹잎이며 좁은 달걀모양 타원형 또는 좁은 달걀모양이다. 끝의 작은 잎은 작은 잎자루와 더불어 길이 4∼8cm, 너비 2∼3cm로서 끝이 뾰족하고 앞면 잎맥 위에 잔털이 있으며 가장자리에 톱니가 있다. 차의 원료이며 건강약초로서 비만, 신경통, 고혈압에 효과가 있고, 중국에서는 만성기관지염, 지해(止咳), 거담(祛痰), 소염해독 치료에 쓰인다. 본 발명에서는 돌외의 잎, 줄기 또는 전초가 사용된다.Gynostemma pentaphyllum is a perennial vine of the dicotyledonous gourd family. It grows in forests of mountains and fields. The rhizome stretches to the side, has white hairs at the nodes, grows tangled, but climbs up with tendrils. Leaves are alternate, compound leaves with 5 small leaves, narrow egg-shaped elliptical or narrow egg-shaped. The small leaf at the end is 4-8cm long and 2-3cm wide with a small petiole, has a sharp tip, has fine hairs on the front leaf vein, and has sawtooth on the edge. It is a raw material of tea and is effective for obesity, neuralgia, and high blood pressure as a health herb. In the present invention, leaves, stems or outposts other than stone are used.
붉은토끼풀(Trifolium pratense)은 쌍떡잎식물 장미목 콩과의 여러해살이풀이다. 홍차축조, 붉은토끼풀꽃, 홍삼엽(紅三葉), 금화채(金花菜)라고도 하며 유럽 원산지이다. 풀밭에서 자란다. 높이 30∼60cm까지 자라며 전체에 털이 있다. 잎은 어긋나고 3개로 갈라진 겹잎이다. 작은 잎은 긴 타원형으로 끝이 둥글거나 다소 파이며 가장자리에 잔 톱니가 있고 표면 중앙에 八자의 흰 무늬가 있다. 턱잎은 잎자루의 밑부분에 붙어 있고 끝이 뾰족하고 가장자리는 밋밋하다. 꽃은 6∼7월에 피고 홍색빛을 띤 자주색을 띠며 잎겨드랑이에 둥글게 모여 달린다. 꽃받침은 통 모양으로 끝이 5개로 갈라지고 뾰족하며 털이 많다. 식물체의 수명이 짧으나 뿌리는 깊게 들어간다. 사료로 심고 있으나 번져나간 것이 야생상으로 자라고 있다. 토끼풀과 비슷하지만 꽃자루가 거의 없고 포가 없으며 원줄기에 퍼진 털이 있다. 유럽에서 널리 재배하고 있다. 본 발명에서는 붉은토끼풀의 잎, 줄기 또는 전초가 사용된다.Red clover (Trifolium pratense) is a dicotyledonous perennial plant belonging to the rose order legume family. It is also called black tea construction, red clover flower, red ginseng leaf (紅三葉), and gold flower leaf (金花菜) and is native to Europe. grows in grass It grows up to 30~60cm in height and has hairs all over. Leaves are alternate and compound leaves divided into 3 parts. The small leaf is a long oval shape with a round end or slightly hollowed out, fine sawtooth on the edge, and a white pattern of the number 8 in the center of the surface. The stipule is attached to the lower part of the petiole, and the end is pointed and the edge is flat. Flowers bloom in June-July, are reddish purple, and hang round in the axils. The calyx is tubular, the tip split into 5, pointed, and has many hairs. The lifespan of the plant is short, but the roots go deep. It is planted as fodder, but the spread is growing wild. It is similar to Shamrock, but has almost no peduncle, no bracts, and has scattered hairs on the main stem. It is widely cultivated in Europe. In the present invention, the leaves, stems or outposts of red clover are used.
서양송악(Hedera Helix)은 쌍떡잎식물 산형화목 두릅나무과의 상록덩굴식물이다. 서양송악은 유럽·북아프리카에 널리 분포하며 한국에는 관엽식물로 도입되어 헬릭스라는 이름으로 보급되었다. 원생지에서는 높이가 30m까지 자란다. 잎은 어긋나고 광택이 있는 짙은 녹색이며 길이가 10cm이고 3∼5갈래로 갈라지며, 늙은 가지의 잎은 갈라지지 않고 달걀모양이다. 어린 가지와 작은 꽃자루에 회색을 띤 흰색의 성모(星毛:여러 갈래로 갈라져 별 모양으로 된 털)가 있다. 꽃은 양성화이고 산형꽃차례를 이루며 달린다. 꽃잎은 5개이고 수술과 암술대도 각각 5개이며, 씨방은 5실이다.원예품종에는 여러 종이 있는데, 대표종인 3색종의 잎은 크고 녹색 바탕에 연한 녹색과 우윳빛 무늬가 불규칙하게 있으며 낮은 기온에서 우윳빛 부분이 연한 붉은빛으로 물든다. 본 발명에서는 서양송악의 잎이 사용된다.Western songak (Hedera Helix) is an evergreen vine plant of the dicotyledonous umbel Araliaceae. Western songak is widely distributed in Europe and North Africa, and was introduced as a houseplant in Korea and spread under the name Helix. In the original habitat, it grows up to 30 m in height. Leaves are alternate, glossy dark green, 10 cm long, split into 3 to 5 branches, and the leaves of old branches are egg-shaped without splitting. On young branches and pedicels, there are grayish-white stray hairs (star-shaped hairs split into several branches). Flowers are bisexual and run in an umbel. There are 5 petals, 5 stamens and 5 styles each, and 5 ovaries. There are several types of horticultural varieties, and the representative species, the tricolor species, has large leaves with light green and milky patterns on a green background, irregularly, and milky at low temperatures. The part is stained with a light red color. In the present invention, the leaves of Western Songak are used.
본 발명은 상기 돌외, 붉은토끼풀 및 서양송악잎을 발효시켜 추출함으로써 복합발효추출물을 제조하고, 이를 화장료로 이용하는 기술에 관한 것이다. The present invention relates to a technique for producing a complex fermented extract by fermenting and extracting the above-mentioned stone, trifolium pratense, and pine chinensis leaves, and using it as a cosmetic.
바람직하게는 상기 복합발효추출물은 돌외, 붉은토끼풀 및 서양송악잎 혼합물을 유산균으로 발효하고 추출하여 제조되는 것임을 특징으로 한다.Preferably, the composite fermented extract is characterized in that it is prepared by fermenting and extracting a mixture of stone, red clover, and pine pine leaf mixture with lactic acid bacteria.
발효에 사용되는 상기 유산균으로는 락토바실러스 플란타룸(Lactobacillus plantarum), 락토코커스 락티스(Lactococccus lactis), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 람노서스(Lactobacillus rhamnosus), 페디오코커스 세레비시애(Pediococcus cereviciae), 락토바실러스 브레브(Lactobacillus breve), 류코노스톡 메센테로이드(Leuconostoc mesenteroides), 비피도박테리움 비피둠(Bifidobacterium bifidum), 락토바실러스 사케이(Lactobacillus sakei) 및 락토바실러스 크리스파투스(Lactobacillus crispatus)로 이루어지는 군으로부터 선택되는 적어도 하나가 사용될 수 있으며, 바람직하게는 락토바실러스 플란타룸(Lactobacillus plantarum)이 사용된다.The lactic acid bacteria used for fermentation include Lactobacillus plantarum, Lactobacillus lactis, Lactobacillus bulgaricus, Lactobacillus rhamnosus, Pediococcus cerevisiae Pediococcus cereviciae, Lactobacillus breve, Leuconostoc mesenteroides, Bifidobacterium bifidum, Lactobacillus sakei and Lactobacillus crispatus (Lactobacillus crispatus) may be used, and preferably Lactobacillus plantarum is used.
본 발명의 일 구체예에 따르면 상기 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물은 다음과 같은 방법에 의하여 제조된다.According to one embodiment of the present invention, the complex fermented extracts of the stone, red clover, and western pine leaves are prepared by the following method.
먼저, 돌외, 붉은토끼풀 및 서양송악잎으로 이루어지는 혼합물을 제조한 후, 정제수에 현탁시키고, 현탁액에 유산균을 접종 및 배양시켜 배양물을 수득한다. 이때, 유산균으로서 락토바실러스 플란타룸(Lactobacillus plantarum)을 사용할 수 있으며, 배양은 25 내지 35℃의 배양 온도에서 1 내지 3일 동안 수행되고, 바람직하게 30℃의 배양 온도에서 약 3일 동안 수행된다. 이에 따라 얻어진 배양물을 원심분리하여 상등액을 수득하고, 이를 여과하여 복합발효추출물을 제조한다.First, after preparing a mixture consisting of stone, trifolium chinensis, and pine chinensis, it is suspended in purified water, and lactic acid bacteria are inoculated and cultured in the suspension to obtain a culture. At this time, Lactobacillus plantarum can be used as the lactic acid bacteria, and the culture is performed at a culture temperature of 25 to 35 ° C for 1 to 3 days, preferably at a culture temperature of 30 ° C for about 3 days. . The resulting culture is centrifuged to obtain a supernatant, which is filtered to prepare a complex fermentation extract.
바람직하게는 상기 혼합물은 돌외, 붉은토끼풀 및 서양송악잎이 각각 1~2 : 1~2 : 1~2의 중량비로 혼합되어 이루어지는 것이며, 더욱 바람직하게는 각각 2 : 1 : 1의 중량비로 혼합되어 이루어진다.Preferably, the mixture is made by mixing stones, trifolium pratense, and cypress leaves in a weight ratio of 1 to 2: 1 to 2: 1 to 2, respectively, more preferably in a weight ratio of 2: 1: 1 It is done.
본 발명의 다른 구체예에 따르면, 상기 복합발효추출물은 돌외, 붉은토끼풀 및 서양송악잎 각각의 발효추출물을 제조한 후 이를 혼합하여 제조될 수도 있다.According to another embodiment of the present invention, the complex fermented extract may be prepared by preparing fermented extracts of stone, trifolium pratense and western pine leaves, respectively, and then mixing them.
이와 같이 제조된 본 발명의 돌외, 붉은토끼풀 및 서양송악잎의 복합발효추출물은 그 상승 작용에 의하여 우수한 항산화효과(시험예 1), 피부 염증 및 자극완화, 아토피 피부 개선 효과(시험예 2 내지 4), 피부 보습효과(시험예 5) 및 피부장벽강화효과(시험예 6)를 나타내는 것을 확인하였다.The composite fermented extracts of the present invention prepared in this way have excellent antioxidant effects (Test Example 1), skin inflammation and irritation relief, and atopic skin improvement effects (Test Examples 2 to 4) by their synergistic action. ), skin moisturizing effect (Test Example 5) and skin barrier strengthening effect (Test Example 6) were confirmed.
유효성분으로서의 상기 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물은 화장료 조성물 총 중량에 대하여 0.01~15 중량%의 양으로 첨가될 수 있다. 0.01중량% 미만으로 첨가되는 경우 그 효과가 약하며, 15중량%를 초과하는 경우에는 함량 증가에 비하여 그 효과의 증가가 감소되어 오히려 비효율적이다. In addition to the active ingredients, the complex fermented extract of chinensis, red clover, and pine pine leaf may be added in an amount of 0.01 to 15% by weight based on the total weight of the cosmetic composition. When added at less than 0.01% by weight, the effect is weak, and when it exceeds 15% by weight, the increase in the effect is reduced compared to the increase in content, which is rather inefficient.
본 발명의 화장료 조성물은 일반적인 유화 제형 및 가용화 제형의 형태로 제조할 수 있다. 유화 제형의 화장품으로는 영양화장수, 크림, 에센스 등이 있으며, 가용화 제형의 화장품으로는 유연화장수가 있다. 또한, 화장품 이외에도 피부 과학적으로 허용 가능한 매질 및 기제를 함유함으로써 피부과학 분야에서 통상적으로 사용되는 국소 적용 및 전신 적용할 수 있는 보조제 형태로 제조될 수 있다.The cosmetic composition of the present invention can be prepared in the form of a general emulsified formulation and a solubilized formulation. Emulsified cosmetics include nutrition lotion, cream, essence, etc., and solubilized cosmetics include softening lotion. In addition, by containing a dermatologically acceptable medium and base other than cosmetics, it can be prepared in the form of an adjuvant that can be applied topically and systemically, which is commonly used in the field of dermatology.
또한 본 발명에서 상기 화장료 조성물의 제형은 제한되지는 않으나 스킨로션, 스킨 소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지 크림, 영양크림, 모이스처 크림, 핸드크림, 에센스, 팩, 비누, 샴푸, 트리트먼트, 클렌징 폼, 클렌징 로션, 클렌징 크림, 바디로션, 바디클렌져, 유액, 프레스파우더, 루스파우더 및 아이새도로 구성된 그룹에서 선택된 어느 하나의 제형으로 적용되어질 수 있다. In addition, the formulation of the cosmetic composition in the present invention is not limited, but skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nutrient lotion, massage cream, nutrient cream, moisture cream, hand cream, essence, It may be applied in any one formulation selected from the group consisting of pack, soap, shampoo, treatment, cleansing foam, cleansing lotion, cleansing cream, body lotion, body cleanser, emulsion, press powder, loose powder, and eye shadow.
[실시예][Example]
이하, 본 발명을 하기 실시예 및 시험예에 의거하여 더욱 상세하게 설명하고자 한다. 단, 하기 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명은 하기 실시예에 의해 한정되는 것이 아니다.Hereinafter, the present invention will be described in more detail based on the following examples and test examples. However, the following examples are only for illustrating the present invention, and the present invention is not limited by the following examples.
실시예 1 ~ 6: 복합발효추출물의 제조Examples 1 to 6: Preparation of composite fermented extract
건조 후 분쇄된 돌외, 붉은토끼풀, 서양송악잎을 하기 표 1의 비율로 혼합한 후, 건조 중량의 10배에 해당하는 정제수에 현탁시키고, 이후에 121℃에서 15분 동안 멸균 처리하였다. 멸균된 배지에 유산균(Lactobacillus plantarum)을 접종하여 30℃의 온도에서 3일 동안 발효하였다.After drying, pulverized stones, red clover, and pine pine leaves were mixed in the ratio shown in Table 1 below, suspended in purified water corresponding to 10 times the dry weight, and then sterilized at 121 ° C. for 15 minutes. Lactobacillus plantarum was inoculated into the sterilized medium and fermented for 3 days at a temperature of 30°C.
발효가 끝난 배양물을 연속 원심분리를 이용하여 7,000 rpm으로 상등액을 분리하였다. 0.45 ㎛ 필터가 장착된 막 여과기(membrane filtrator)를 사용하여 상등액으로부터 유산균(Lactobacillus plantarum)을 제거하여, 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물을 수득하였다.The supernatant was separated from the fermented culture using continuous centrifugation at 7,000 rpm. Lactobacillus plantarum was removed from the supernatant using a membrane filter equipped with a 0.45 μm filter to obtain composite fermented extracts of Dole, chinensis chinensis, and Pine chinensis.
비교예 1~3: 혼합추출물의 제조 Comparative Examples 1 to 3: Preparation of mixed extracts
건조 후 분쇄된 돌외, 붉은토끼풀, 서양송악잎을 하기 표 2의 비율로 혼합한 후, 건조 중량의 10배에 해당하는 정제수를 첨가하고, 121℃에서 2시간 동안 추출하였다. 이 후에 2G3 Glass-filter(PYREX 32940 FNL, JAPAN)를 사용하여 여과한 다음 열수추출물을 획득하였다.After drying, pulverized stone, red clover, and pine pine leaves were mixed in the ratio shown in Table 2 below, and then purified water corresponding to 10 times the dry weight was added and extracted at 121 ° C. for 2 hours. After this, it was filtered using a 2G3 Glass-filter (PYREX 32940 FNL, JAPAN) and then a hot water extract was obtained.
시험예 1: 항산화 효과Test Example 1: Antioxidant effect
실시예 1~6과 비교에 1~3의 시료에 대하여 프리라디칼 소거능 측정을 통해 항산화 효과를 측정하였다.In comparison with Examples 1 to 6, the antioxidant effect was measured by measuring the free radical scavenging ability for the samples 1 to 3.
시료에 대한 전자공여능 측정은 다음과 같이 실시하였다. 각 시료의 농도별 용액 100㎕에 5×10-4 M의 DPPH(1-1-diphenyl-2-picryl-hydrazyl) 100㎕를 넣고, 1분간 교반한 후, 25℃ 인큐베이터에서 30분간 반응시킨 후, 마이크로플레이트 계수기를 이용하여 517nm에서 흡광도를 측정하였다. 실결과값을 비교하기 위하여 자유 라디칼 소거활성이 우수한 것으로 알려진 비타민 C를 대조군으로 사용하여 실험을 진행하였다. 결과는 하기 표 3에 나타내었다.The electron donating ability of the sample was measured as follows. 100 μl of 5 × 10 -4 M DPPH (1-1-diphenyl-2-picryl-hydrazyl) was added to 100 μl of the solution for each concentration of each sample, stirred for 1 minute, and reacted for 30 minutes in a 25 ° C incubator. , and absorbance was measured at 517 nm using a microplate counter. In order to compare the actual results, the experiment was conducted using vitamin C, which is known to have excellent free radical scavenging activity, as a control group. The results are shown in Table 3 below.
(비타민 C)control group
(Vitamin C)
상기 표 3에서 알 수 있듯이 실시예와 비교예 시료 모두 프리라디칼 소거능을 나타내었으며, 특히, 돌외, 붉은토끼풀 및 서양송악잎을 유산균으로 발효추출한 실시예 4~6의 복합발효추출물에서 더욱 강력한 프리라디칼로 인한 세포 손상 및 피부노화 진행을 억제하는 효과가 우수함을 확인하였다.As can be seen from Table 3, both the examples and the comparative samples showed free radical scavenging ability. It was confirmed that the effect of inhibiting cell damage and skin aging due to was excellent.
시험예 2: 자극에 의한 COX-2 및 PGE-2 발현 감소 효과 Test Example 2: COX-2 and PGE-2 expression reduction effect by stimulation
Human Epidermal Keratinocyte(HaCaT)의 cytokine 생성에 미치는 영향을 알아보기 위하여 96 well plate에 5×105cells/ml의 cell을 100 ul씩 넣은 후, CO2배양기에서 48시간 배양한 뒤 배지를 버린 다음, 표면을 PBS 용액으로 세척 한 후, FBS가 첨가되지 않은 배지로 교체하여 18시간 starvation 시키고, 24시간 동안 배양하였다. 배양 후 자극 요인 UV-B (100mJ/cm2), LPS(10ng/ml), SLS(10ppm)을 각각 처리하여 세포에 자극을 준 후, 상기 실시예 1~6 및 비교예 1~3의 각 시료 0.1% 씩 처리하고, 24시간 배양한 후 RT-PCR을 이용하여 mRNA 발현량을 조사하였다.In order to examine the effect on cytokine production of Human Epidermal Keratinocyte (HaCaT), 100 ul of 5×10 5 cells/ml cells were put into a 96 well plate, cultured in a CO 2 incubator for 48 hours, and then the medium was discarded. After washing the surface with a PBS solution, the medium was replaced with a medium without FBS, followed by starvation for 18 hours and cultured for 24 hours. After culturing, stimulation factors UV-B (100mJ/cm 2 ), LPS (10ng/ml), and SLS (10ppm) were treated to stimulate the cells, and then each of Examples 1 to 6 and Comparative Examples 1 to 3 Samples were treated with 0.1% each, and after culturing for 24 hours, the amount of mRNA expression was examined using RT-PCR.
상기 각각의 자극요인에 의해 증가된 mRNA 발현량을 대조군으로 하여 하기 식에 의해 발현감소율을 계산하였고, 그 결과는 표 4에 나타내었다.Using the mRNA expression level increased by each of the stimulating factors as a control, the expression decrease rate was calculated by the following formula, and the results are shown in Table 4.
mRNA 발현감소율(%)=[1-(시료 mRNA 발현양/대조군 mRNA 발현양)]×100mRNA expression reduction rate (%) = [1-(sample mRNA expression amount / control group mRNA expression amount)] × 100
상기 표 4에서 확인되는 바와 같이, 본 발명 실시예 4~6의 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물은 다른 실시예 및 비교예의 시료에 비하여 자극에 의해 유도된 염증인자인 COX-2 및 PGE-2의 발현을 더욱 감소시켰으며, 실시예 5에서 가장 우수한 효과를 나타내었다.As confirmed in Table 4, the complex fermented extracts of P. chinensis, P. chinensis, and Pine pine leaf of Examples 4 to 6 of the present invention were compared to the samples of other Examples and Comparative Examples, and COX-2, an inflammatory factor induced by stimulation, and The expression of PGE-2 was further reduced, and the most excellent effect was shown in Example 5.
시험예 3: 자극에 의한 NF-kB 및 TNF-α 발현감소 효과 Test Example 3: Effect of reducing NF-kB and TNF-α expression by stimulation
Human Epidermal Keratinocyte(HaCaT)의 cytokine 생성에 미치는 영향을 알아보기 위하여 96 well plate에 5×105cells/ml의 cell을 100 ul씩 넣은 후, CO2배양기에서 48시간 배양한 뒤 배지를 버린 다음, 표면을 PBS 용액으로 세척한 후, FBS가 첨가되지 않은 배지로 교체하여 18시간 starvation 시키고, 24시간 동안 배양하였다. 배양 후 자극요인 UV-B (100mJ/cm2), LPS(10ng/ml), SLS(10ppm)를 처리하여 세포에 자극을 준 후, 상기 실시예 및 비교예의 각 시료 0.1% 씩 처리하고, 24시간 배양 한 후 세포는 RT-PCR을 이용하여 mRNA 발현량을 조사하였다.In order to examine the effect on cytokine production of Human Epidermal Keratinocyte (HaCaT), 100 ul of 5×10 5 cells/ml cells were put into a 96 well plate, cultured in a CO 2 incubator for 48 hours, and then the medium was discarded. After washing the surface with a PBS solution, the medium was replaced with a medium without FBS, followed by starvation for 18 hours and cultured for 24 hours. After culturing, the cells were stimulated by treatment with stimulation factors UV-B (100mJ/cm 2 ), LPS (10ng/ml), and SLS (10ppm), and then treated with 0.1% of each sample in Examples and Comparative Examples, 24 After culturing for a period of time, the cells were examined for mRNA expression using RT-PCR.
상기 각각의 자극요인에 의해 증가된 mRNA 발현량을 대조군으로 하여 하기 식에 의해 발현감소율을 산출하였고, 그 결과는 표 5에 나타내었다.Using the mRNA expression level increased by each of the stimulating factors as a control, the expression decrease rate was calculated by the following formula, and the results are shown in Table 5.
mRNA 발현감소율(%)=[1-(시료 mRNA 발현양/대조군 mRNA 발현양)]×100mRNA expression reduction rate (%) = [1-(sample mRNA expression amount / control group mRNA expression amount)] × 100
상기 표 5에서 확인되는 바와 같이, 본 발명 실시예 4~6의 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물은 다른 실시예 및 비교예 1~3의 시료에 비하여 자극에 의해 유도된 염증인자 NF-kB 및 TNF-α의 발현을 더욱 감소시키는 것을 알 수 있다.As confirmed in Table 5, the composite fermented extracts of P. chinensis, P. chinensis, and Pine pine leaf of Examples 4 to 6 of the present invention were compared to the samples of other Examples and Comparative Examples 1 to 3, inflammatory factor NF induced by stimulation -kB and TNF-α expression It can be seen that further reduction
시험예 4: β-디펜신 분비 촉진 효과 시험Test Example 4: β-defensin secretion promoting effect test
상기 실시예 및 비교예의 추출물을 시료로하여 피부 면역 장벽 기능을 증대시키고, 아토피 피부 개선활성을 가지는 인간 유래 항균 펩타이드인 β-디펜신-2(hBD-2, Human -defensin-2)의 발현에 영향을 미치는 정도를 측정하였다.For the expression of β-defensin-2 (hBD-2, Human -defensin-2), a human-derived antibacterial peptide having the extracts of the above Examples and Comparative Examples to increase the skin immune barrier function and improve atopic skin, as samples The degree of influence was measured.
HaCaT 세포를 6 well plate에 1×106cells/well의 농도로 분주하여 배양한 후, FBS가 첨가되지 않은 배지로 교체하여 18시간 starvation 시키고, 24시간 동안 배양하였다. HaCaT 세포에 각 시료 1.0%씩 처리하고, 24시간 배양 한 후 세포는 RT-PCR을 이용하여 Human-defensin-2(hBD-2) mRNA 발현량을 조사하였다. 그 결과는 도 1에 나타내었다.HaCaT cells were cultured by dispensing at a concentration of 1×10 6 cells/well in a 6-well plate, and then replaced with FBS-free medium, starvated for 18 hours, and cultured for 24 hours. HaCaT cells were treated with 1.0% of each sample, and after culturing for 24 hours, the cells were examined for Human-defensin-2 (hBD-2) mRNA expression using RT-PCR. The results are shown in Figure 1.
도 1에서 확인되는 바와 같이, 동일 농도 처리시 실시예 4~6의 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물은 다른 실시예나 비교예의 추출물 시료 보다 우수한 β-디펜신-2 발현 증가 효과를 나타내었다.As confirmed in Figure 1, when treated at the same concentration, the combined fermented extracts of P. chinensis, P. chinensis, and Pine leaf of Examples 4 to 6 showed a superior effect of increasing β-defensin-2 expression than the extract samples of other Examples or Comparative Examples. was
그 중에서도 실시예 5의 복합발효추출물물은 보다 더 우수한 발현 증가 효과를 나타내었으며, 대조군인 피메클로리무스와 비교해도 비슷한 효과를 나타내어 아토피 개선활성이 우수하다는 것을 확인할 수 있었다.Among them, the complex fermented extract of Example 5 showed a more excellent expression increasing effect, and compared to the control pimecrolimus, it showed a similar effect, confirming that the atopy improving activity was excellent.
시험예 5: Hyaluronic acid 생성량 측정Test Example 5: Measurement of hyaluronic acid production
상기 실시예 및 비교예의 시료에 대하여 Hyaluronic acid 생성량을 측정하였다. HaCaT 세포를 96 well plate에 1×105cells/well의 농도로 분주하여 배양한 후, FBS가 첨가되지 않은 배지로 교체하여 18시간 starvation 시키고, 24시간 동안 배양하였다. HaCaT 세포에 각 시료 0.1%씩 처리하고, 24시간 배양한 후 회수한 배양액은 ELSIA kit를 이용하여 hyaluronic acid(HA) 생성량을 측정하였다. 그 결과는 표 6에 나타내었다.Hyaluronic acid production was measured for the samples of Examples and Comparative Examples. HaCaT cells were cultured by dispensing in a 96 well plate at a concentration of 1×10 5 cells/well, then replaced with FBS-free medium, starvated for 18 hours, and cultured for 24 hours. HaCaT cells were treated with 0.1% of each sample, cultured for 24 hours, and the collected culture medium was measured for hyaluronic acid (HA) production using an ELSIA kit. The results are shown in Table 6.
상기 표 6에서 확인되는 바와 같이, 본 발명 실시예 4~6의 돌외, 붉은토끼풀 및 서양송악잎의 복합발효추출물은 보다 높은 Hyaluronic acid 생성량을 나타내었다.As confirmed in Table 6, the composite fermented extracts of P. chinensis, P. chinensis, and Pine pine leaf of Examples 4 to 6 of the present invention showed higher production of hyaluronic acid.
실시예 7: 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물 함유 세럼의 제조Example 7: Preparation of Serum Containing Complex Fermented Extracts of Stone, Red Clover, and Western Pine Leaf
상기 실시예 5의 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물을 포함하는 세럼을 하기 표 7의 조성 및 함량으로 통상의 방법에 따라 제조하였다.A serum containing the complex fermented extracts of dolweed, trifolium pratense, and pine pine leaf of Example 5 was prepared according to a conventional method with the composition and content shown in Table 7 below.
시험예 6: 피부 장벽기능 강화 효과 확인Test Example 6: Confirmation of skin barrier function strengthening effect
피부 장벽기능 강화 효과를 확인하기 위해, 사람의 상박에 테이핑 스트리핑 방법(Taping stripping Method)을 이용하여 피부의 장벽을 손상시킨 후, 상기 실시예 7 및 비교예 4에서 제조한 세럼 각각을 5cm2 면적에 도포한 후, 표피 수분손실량(TEWL, Transdermal water loss)을 3시간, 6시간, 12시간, 24시간 경과 후에 측정하여 감소하는 정도를 평가함으로써 장벽기능이 강화되는 정도를 평가하였다. 표피 수분 손실량은 Cortex Technology 사 (덴마크) DermaLab Combo로 측정하였다. 결과는 초기 손상된 장벽 상태에서의 표피 수분손실량을 기준(100%)으로 하여 시간에 따른 변화를 비교한 후, 하기 표 8에 나타내었다.In order to confirm the effect of enhancing the skin barrier function, after damaging the skin barrier using the taping stripping method on the upper arm of a person, the serums prepared in Example 7 and Comparative Example 4 were applied to a 5 cm 2 area After application, the degree of enhancement of the barrier function was evaluated by evaluating the degree of reduction by measuring the amount of transdermal water loss (TEWL) after 3 hours, 6 hours, 12 hours, and 24 hours. The amount of epidermal water loss was measured by DermaLab Combo from Cortex Technology (Denmark). The results are shown in Table 8 below after comparing the change over time based on the amount of epidermal water loss in the initial damaged barrier state (100%).
표 8에서 확인되는 바와 같이, 피부 장벽 기능 강화 시험 결과 본 발명의 돌외, 붉은토끼풀 및 서양송악잎 복합발효추출물을 함유한 실시예 7의 세럼 조성물은 이를 함유하지 않은 비교예 4의 조성물에 비해 우수한 피부 장벽기능 강화 효과를 나타내었다.As confirmed in Table 8, as a result of the skin barrier function enhancement test, the serum composition of Example 7 containing the complex fermented extracts of P. chinensis, Red clover, and Pine chinensis of the present invention was superior to the composition of Comparative Example 4 without them. It showed the effect of strengthening the skin barrier function.
Claims (8)
According to claim 1, wherein the cosmetic composition is a cosmetic composition characterized in that for skin moisturizing or for strengthening the skin barrier.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230003704A KR102546410B1 (en) | 2023-01-10 | 2023-01-10 | Cosmetic composition for improving atopic dermatitis, skin moisturizing and skin soothing containing fermented extracts of Gynostemma pentaphyllum, Trifolium pratense and Hedera Helix |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230003704A KR102546410B1 (en) | 2023-01-10 | 2023-01-10 | Cosmetic composition for improving atopic dermatitis, skin moisturizing and skin soothing containing fermented extracts of Gynostemma pentaphyllum, Trifolium pratense and Hedera Helix |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102546410B1 true KR102546410B1 (en) | 2023-06-22 |
Family
ID=86988856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020230003704A Active KR102546410B1 (en) | 2023-01-10 | 2023-01-10 | Cosmetic composition for improving atopic dermatitis, skin moisturizing and skin soothing containing fermented extracts of Gynostemma pentaphyllum, Trifolium pratense and Hedera Helix |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102546410B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102706987B1 (en) * | 2023-12-28 | 2024-09-13 | (주)올바름디앤비 | A skin trouble alleviating and skin soothing cosmetic composition containing Chamaecyparis Obtusa extract, Melaleuca Alternifolia extract, Mentha Suaveolens extract, Rosmarinus Officinalis extract, Trifolium Pratense extract, centella asiatica extract and beta-glucan as active ingredients. |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100667448B1 (en) | 2005-09-01 | 2007-01-10 | 주식회사 쵸이스코스메틱 | Cosmetic composition containing dodol extract |
KR101599254B1 (en) | 2015-08-11 | 2016-03-04 | 주식회사 비앤비코리아 | Cosmetic composition for skin moisturizer |
CN105770066A (en) * | 2016-03-05 | 2016-07-20 | 三株福尔制药有限公司 | Probiotic fermented traditional Chinese medicine compound preparation and preparation method and application thereof |
KR20170019305A (en) * | 2016-02-24 | 2017-02-21 | 주식회사 비앤비코리아 | Cosmetic composition for skin moisturizer |
KR20170118359A (en) * | 2016-04-15 | 2017-10-25 | 김세인 | Cosmetic composition containing gynostemma pentaphyllum leaf extract |
KR20210135034A (en) * | 2020-05-04 | 2021-11-12 | 주식회사 엘라플로스 | Composition for improving skin barrier comprising herb extracts mixture |
KR20220055190A (en) | 2020-10-26 | 2022-05-03 | 주식회사 이지하이드로젠 | Cosmetic composition comprising fermented extract of Gynostemma pentaphyllum |
-
2023
- 2023-01-10 KR KR1020230003704A patent/KR102546410B1/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100667448B1 (en) | 2005-09-01 | 2007-01-10 | 주식회사 쵸이스코스메틱 | Cosmetic composition containing dodol extract |
KR101599254B1 (en) | 2015-08-11 | 2016-03-04 | 주식회사 비앤비코리아 | Cosmetic composition for skin moisturizer |
KR20170019305A (en) * | 2016-02-24 | 2017-02-21 | 주식회사 비앤비코리아 | Cosmetic composition for skin moisturizer |
CN105770066A (en) * | 2016-03-05 | 2016-07-20 | 三株福尔制药有限公司 | Probiotic fermented traditional Chinese medicine compound preparation and preparation method and application thereof |
KR20170118359A (en) * | 2016-04-15 | 2017-10-25 | 김세인 | Cosmetic composition containing gynostemma pentaphyllum leaf extract |
KR20210135034A (en) * | 2020-05-04 | 2021-11-12 | 주식회사 엘라플로스 | Composition for improving skin barrier comprising herb extracts mixture |
KR20220055190A (en) | 2020-10-26 | 2022-05-03 | 주식회사 이지하이드로젠 | Cosmetic composition comprising fermented extract of Gynostemma pentaphyllum |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102706987B1 (en) * | 2023-12-28 | 2024-09-13 | (주)올바름디앤비 | A skin trouble alleviating and skin soothing cosmetic composition containing Chamaecyparis Obtusa extract, Melaleuca Alternifolia extract, Mentha Suaveolens extract, Rosmarinus Officinalis extract, Trifolium Pratense extract, centella asiatica extract and beta-glucan as active ingredients. |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101829892B1 (en) | A cosmetic composition comprising fraxinus rhynchophylla extract and calystegia soldanella extract | |
KR101825704B1 (en) | A cosmetic composition comprising coffee silver skin extract | |
KR20080068160A (en) | Anti-aging cosmetic composition | |
KR102004366B1 (en) | A cosmetic composition comprising centipeda minima extract | |
KR102113645B1 (en) | A cosmetic composition for preventing hair loss and promoting hair growth containing spicule powder and natural extract | |
KR102145113B1 (en) | Cosmetic composition containing sarcodon aspratus and magnolia liliflora buda fermented extract using Yusung hot spring water | |
KR102032873B1 (en) | Antioxidant and moisturizing cosmetic composition | |
KR102546410B1 (en) | Cosmetic composition for improving atopic dermatitis, skin moisturizing and skin soothing containing fermented extracts of Gynostemma pentaphyllum, Trifolium pratense and Hedera Helix | |
KR101819060B1 (en) | Cosmetic Compositions Containing Fermented Extracts of Hwangryunhaedoktang | |
KR102364260B1 (en) | Cosmetic composition for skin soothing containing complex extract including Gynostemma pentaphyllum, Saponaria officinalis L. and Lonicera Japonica Flower | |
KR102238800B1 (en) | Composition for strengthening hair containing natural extracts | |
KR101829891B1 (en) | A cosmetic composition comprising osmanthus asiaticus extract and clematis apiifolia extract | |
KR102350749B1 (en) | Functional cosmetic composition with excellent skin anti-aging activity, skin moisturizing and skin soothing effect including fruit extract | |
KR20050106710A (en) | A composition for skin external application | |
KR102100345B1 (en) | A cosmetic composition comprising ligustrum lucidum extract | |
KR20110032715A (en) | Anti-aging cosmetic composition and preparation method thereof | |
KR101710005B1 (en) | Cosmetic composition comprising cheonjeongpalgindan as active ingredient | |
KR102528279B1 (en) | Composition for improving skin conditions comprising pottery fermented herbal mixture | |
KR102646545B1 (en) | Cosmetic composition for skin whitening or skin barrier improvement comprising Hosta longipes extract | |
KR102162917B1 (en) | Cosmetic composition comprising complex extracts of Artemisia absinthium, Belamcanda chinensis, Sedum sarmentosum, Solidago virgaurea and Actinidia polygama | |
KR102006665B1 (en) | Anti-oxidant, anti-inflammatory, whitening and moisturizing cosmetic composition comprising the mixed herbal extract of silver weed, heather, and milk thistle as an active ingredient and preparation method of the same | |
KR102454297B1 (en) | Cosmetic composition for anti-oxidation, anti-inflammation or skin improvement containing propolis fermented extracts | |
KR101081585B1 (en) | Cosmetic composition containing extract of ligustrum japonicum and hemerocallis fulva for improving skin wrinkle | |
KR101998685B1 (en) | A cosmetic composition comprising arenaria serpyllifolia extract | |
KR102076655B1 (en) | A cosmetic composition for slimming containing spicule powder and curcuma longa extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20230110 |
|
PA0201 | Request for examination | ||
PA0302 | Request for accelerated examination |
Patent event date: 20230111 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20230110 Patent event code: PA03021R01I Comment text: Patent Application |
|
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20230218 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20230612 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20230619 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20230619 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration |